Neogenomics (NEO) Return on Sales (2010 - 2026)

Neogenomics (NEO) has 17 years of Return on Sales data on file, last reported at 0.0% in Q2 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales rose to 0.0% in Q2 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q2 2026 to a low of 0.0% in Q1 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• The widest YoY moves for Return on Sales: up 0 bps in 2022, down 1 bps in 2022.
• Tracing NEO's Return on Sales over 5 years: stood at 0.0% in 2022, then jumped by 44 bps to 0.0% in 2023, then climbed by 3 bps to 0.0% in 2024, then surged by 42 bps to 0.0% in 2025, then surged by 121 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q2 2026), 0.0% (Q1 2026), and 0.0% (Q4 2025), per Business Quant data.